Click here for the new white paper: ''Making Coverage Count: Screening for CFTR Mutations in Diverse Populations with Effective Variants Panels''.


  • The Asuragen CFTR assay is designed based on the latest data from nearly 500K individuals with diverse ethnic backgrounds
  • This modern design offers 5-14% improved variant coverage in pan-ethnic populations, significantly improving detection of carriers
  • Improved coverage directly translates to improved clinical outcomes and reduced CF prevalence, driving the need for best-in-class coverage only we can deliver

Click here for the video from Asuragen.